These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11216764

  • 1. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
    Kim K, Park SJ, Kim BT, Lee KS, Shim YM.
    Ann Thorac Surg; 2001 Jan; 71(1):290-4. PubMed ID: 11216764
    [Abstract] [Full Text] [Related]

  • 2. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS.
    Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
    [Abstract] [Full Text] [Related]

  • 3. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 4. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 5. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, Liu QW.
    Asian Pac J Cancer Prev; 2014 Jan 01; 15(18):7719-24. PubMed ID: 25292052
    [Abstract] [Full Text] [Related]

  • 6. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.
    Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459
    [Abstract] [Full Text] [Related]

  • 7. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov 15; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 8. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 9. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
    Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, Kim BT.
    J Nucl Med; 2000 May 20; 41(5):808-15. PubMed ID: 10809196
    [Abstract] [Full Text] [Related]

  • 10. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
    Yu W, Fu XL, Zhang YJ, Xiang JQ, Shen L, Chang JY.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e759-65. PubMed ID: 21470788
    [Abstract] [Full Text] [Related]

  • 11. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
    Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P, Deneffe G, Van Raemdonck D, Mortelmans L.
    Ann Surg; 2000 Dec 01; 232(6):743-52. PubMed ID: 11088069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul 01; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2013 May 01; 49(5):449-53. PubMed ID: 23321549
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul 01; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 20. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
    Park SY, Kim DJ, Jung HS, Yun MJ, Lee JW, Park CK.
    World J Surg; 2015 Dec 01; 39(12):2948-54. PubMed ID: 26324159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.